AI Prime
company
About
AI Prime is a life sciences company focused on developing oncology therapeutics targeting the growth and proliferation of cancer cells.
- 1 - 10
Highlights
Details
- Last Funding Type
- Seed
- Industries
- Artificial Intelligence
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
—
AI Prime has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jun 6, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 6, 2022 | Series A | — | 1 |
|
— | Detail |
| Jul 1, 2020 | Seed | — | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
AI Prime is funded by 3 investors.
Suzhou Zhongxin Innovation Investment Management
and Zhidao Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
|
|
— | Seed |
|
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
